ketamin

Phase 1Small molecule

MMassachusetts General Hospital

ketamin is one of 24 small molecule programs targeting Anesthesia. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnesthesiaNot yet recruiting

KetamineNot yet recruiting

AnesthesiaPreclinical

Not yet recruiting

KetaminePhase 1

Not yet recruiting

Competition

Competitive Landscape

30 competitors in Anesthesia

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

10 2

Versed

CConrado Roberto Hoffmann Filho

Approved

4 3

Sufenta

LLeaf Vertical Inc.

Approved

4 4

Iheezo

BB. Braun Medical Inc.

Approved

3 5

Xylocaine

MMEDRx USA, Inc.

Phase 1

12 6

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 1

7 7

Duragesic

CCephalon

Preclinical

6 8

Romazicon

CConrado Roberto Hoffmann Filho

Preclinical

2 9

Ultram

WWim Janssens

Preclinical

1 10

Magnesium

SSpherium Biomed

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

PreclinicalNot yet recruiting

Anesthesia

NCT07787702

Q2 2030

Phase 1Not yet recruiting

Ketamine

NCT06698848

Clinical

Trials by Indication[1]

Dexmedetomidine1 trial

Comparison of Oral Dexmedetomidine, Ketamine Versus Midazolam for Premedication in Children Undergoing Injuinal Surgeries

Completed·TTanta University·N/A·NCT06879496·60 enrolled

Ketamine1 trial

Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome

Not yet recruiting·MMassachusetts General Hospital·Phase 1·NCT06698848·120 enrolled

Anesthesia1 trial

To Compare the Prophylactic Use of Low Doses of Intravenous Ketamine and Tramadol for the Prevention of Post Spinal Anaesthesia Shivering in Orthopedic Surgical Patients at Shaheed Mohtarma Benazir Bhutto Institute of Trauma (SMBBIT) Karachi, Sindh, Pakistan

Not yet recruiting·SShaheed Mohtarma Benazir Bhutto Institue of Trauma·Preclinical·NCT07787702·106 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for ketamin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ketamin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ketamin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Massachusetts General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: MMassachusetts General Hospital

ketamin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Q2 2030

Trials by Indication[1]

Dexmedetomidine1 trial

Ketamine1 trial

Anesthesia1 trial

References

Drug Info

Quick Facts

Related News